Mystic Holdings Past Earnings Performance
Past criteria checks 0/6
Mystic Holdings's earnings have been declining at an average annual rate of -1.8%, while the Pharmaceuticals industry saw earnings growing at 1.7% annually. Revenues have been declining at an average rate of 1.2% per year.
Key information
-1.8%
Earnings growth rate
12.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | -1.2% |
| Return on equity | -5.8% |
| Net Margin | -12.6% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses BreakdownBeta
How Mystic Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 12 | -2 | 5 | 0 |
| 31 Mar 23 | 11 | -2 | 5 | 0 |
| 31 Dec 22 | 10 | -3 | 6 | 0 |
| 30 Sep 22 | 11 | 0 | 6 | 0 |
| 30 Jun 22 | 11 | -1 | 9 | 0 |
| 31 Mar 22 | 13 | -1 | 8 | 0 |
| 31 Dec 21 | 14 | -2 | 8 | 0 |
| 30 Sep 21 | 15 | -4 | 9 | 0 |
| 30 Jun 21 | 15 | -3 | 8 | 0 |
| 31 Mar 21 | 14 | -2 | 7 | 0 |
| 31 Dec 20 | 13 | -1 | 5 | 0 |
| 30 Sep 20 | 11 | -1 | 4 | 0 |
| 30 Jun 20 | 8 | -2 | 2 | 0 |
| 31 Mar 20 | 6 | -2 | 2 | 0 |
| 31 Dec 19 | 4 | -2 | 1 | 0 |
| 31 Dec 18 | 4 | -2 | 1 | 0 |
| 31 Dec 17 | 1 | -1 | 1 | 0 |
Quality Earnings: MSTH is currently unprofitable.
Growing Profit Margin: MSTH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MSTH is unprofitable, and losses have increased over the past 5 years at a rate of 1.8% per year.
Accelerating Growth: Unable to compare MSTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MSTH is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-6.8%).
Return on Equity
High ROE: MSTH has a negative Return on Equity (-5.79%), as it is currently unprofitable.